Aminophylline Administration Guidelines

Critical Safety Concerns

The American College of Chest Physicians recommends that a loading dose of intravenous aminophylline be omitted in patients already taking oral theophyllines to avoid potentially life-threatening toxicity 1
If IV aminophylline is deemed necessary for a patient with severe asthma who has already received oral theophylline, a maintenance infusion without a loading dose should be used 1
The maintenance infusion rate should be 0.5-0.7 mg/kg/hour for patients with severe asthma 1
Serum theophylline levels must be monitored routinely due to wide interpatient variability in metabolism in patients receiving IV aminophylline 1

Aminophylline should only be considered for patients with unsatisfactory progress after initial treatments with nebulized β-agonists and systemic corticosteroids 2
The European Respiratory Society recommends that aminophylline be reserved specifically for patients with life-threatening features or those who fail to improve with first-line therapies 2
Current guidelines emphasize that systemic corticosteroids and inhaled beta-agonists are the primary treatments, with theophylline serving only as adjunctive therapy in severe cases not responding to initial treatment 1

The British Thoracic Society recommends continuing nebulized salbutamol at 4-6 hourly intervals and ensuring systemic corticosteroids are on board before considering IV aminophylline 3
Adding nebulized ipratropium bromide 0.25-0.5 mg may be considered if not already given, especially for severe exacerbations 3
Both salbutamol and ipratropium may be administered together if response to either alone is poor 3

The American College of Chest Physicians recommends starting maintenance infusion at 0.5-0.7 mg/kg/hour and measuring serum theophylline levels daily 1
Monitoring for signs of toxicity continuously and continuing to monitor peak expiratory flow and clinical response is crucial when administering IV aminophylline 1, 2